You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NLRP3 Inflammasome

Showing 151 - 175 of 285
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Metabolic Disease Trial run by the NICHD (Colchicine 0.6Mg Cap, Placebo capsules given, Colchicine 0.6Mg Tab)

Completed
Has Results
  • Obesity
  • Metabolic Disease
  • Colchicine 0.6Mg Cap
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 27, 2019

Coronary Artery Disease Trial in United States (Colchicine, Placebo)

Not yet recruiting
  • Coronary Artery Disease
  • Long Beach, California
  • +4 more
Nov 15, 2022

Hepatitis C Trial (interleukin IL-1beta and interleukin IL-18)

Unknown status
  • Hepatitis C
  • interleukin IL-1beta and interleukin IL-18
  • (no location specified)
Jan 24, 2020

Inflammatory Response Trial (Blueberry-protein gel, Blueberry gel, Placebo)

Not yet recruiting
  • Inflammatory Response
  • Blueberry-protein gel
  • +2 more
  • (no location specified)
Oct 24, 2022

Functional Test for Mediterranean Family Fever Screening - 2

Recruiting
  • Familial Mediterranean Fever
  • MEFV Gene Mutation
  • one additional blood sample during a planned blood test
  • Bron, France
  • +7 more
Nov 15, 2021

Pathogenesis of Physical Induced Urticarial Syndromes

Recruiting
  • Hypersensitivity, Immediate
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2023

    Lupus Nephritis Trial in Alexandria (Dapagliflozin 10mg Tab orally once daily)

    Not yet recruiting
    • Lupus Nephritis
    • Dapagliflozin 10mg Tab orally once daily
    • Alexandria, Egypt
      Ain Shams University
    Oct 27, 2023

    COVID-19 Trial in Abbottabad (Colchicine, Standard COVID-19 care)

    Completed
    • COVID-19
    • Abbottabad, Khyber Pakhtunkhwa, Pakistan
      Ayub Teaching Hospital
    Oct 30, 2021

    New Signaling Pathway Targeting Systemic Lupus Erythematosus

    Unknown status
    • SLE
    • Taking peripheral blood samples
    • (no location specified)
    Jun 27, 2019

    Disorders: Genetics and Disease Characteristics

    Recruiting
    • Familial Mediterranean Fever (FMF)
    • +6 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Anemia, MDS Trial in Germany (Canakinumab Injection)

      Recruiting
      • Anemia
      • Myelodysplastic Syndromes
      • Canakinumab Injection
      • Berlin, Germany
      • +5 more
      Nov 8, 2022

      Diabetic Macular Edema Trial (K8)

      Not yet recruiting
      • Diabetic Macular Edema
      • (no location specified)
      Jan 27, 2023

      Hyperuricemia Trial in Jinhua (Study Product A (High-dose 2X), Study Product B (Low-dose X), Placebo)

      Recruiting
      • Hyperuricemia
      • Study Product A (High-dose 2X)
      • +2 more
      • Jinhua, Zhejiang, China
        Charlie Zhang
      Oct 10, 2023

      Trapezius Myalgia Trial in Lahore (upper trapezius stretching plus neck isometrics, upper trapezius stretching with mid-lower

      Recruiting
      • Trapezius Myalgia
      • upper trapezius stretching plus neck isometrics
      • upper trapezius stretching with mid-lower trapezius strengthening exercises plus neck isometrics
      • Lahore, Punjab, Pakistan
        Bahria International Hospital
      May 11, 2023

      Aging Disorder, Obesity, Inflammation Trial in Ribeirão Preto (Multicomponent Training)

      Recruiting
      • Aging Disorder
      • +2 more
      • Multicomponent Training
      • Ribeirão Preto, Sp, Brazil
        University of São Paulo, School of Physical Education and Sports
      Sep 20, 2022

      Diabetic Cardiomyopathies, Heart Failure Trial in Louisville (Probiotic)

      Not yet recruiting
      • Diabetic Cardiomyopathies
      • Heart Failure
      • Probiotic
      • Louisville, Kentucky
        University of Louisville School of Medicine
      Oct 5, 2022

      Cancer Trial (Empagliflozin 10 MG)

      Not yet recruiting
      • Cancer
      • Empagliflozin 10 MG
      • (no location specified)
      Oct 22, 2023

      Establishment of a Cohort of Patients With Sepsis Encephalopathy

      Not yet recruiting
      • Sepsis Encephalopathy
      • No intervention
      • (no location specified)
      Jan 14, 2020

      Acute Kidney Injury, Renal Calculi, Percutaneous Nephrolithotomy Trial in Cairo (Percutaneous nephrolithotomy, Extracorporeal

      Recruiting
      • Acute Kidney Injury
      • +3 more
      • Percutaneous nephrolithotomy
      • Extracorporeal Shock Wave Lithotripsy
      • Cairo, Egypt
        Urology Department, Faculty of Medicine, Ain Shams University
      Feb 18, 2022

      Predict Sepsis; Predictive Value of Bedside Measures in

      Completed
      • Sepsis
      • +2 more
      • Blood test: Glukos, SuPAR, Laktat and HBP
      • Stockholm, Sweden
        Samariten Ambulans AB
      Oct 25, 2020

      Coronavirus Infection, Diabetes, Type 2 Trial in Switzerland (Canakinumab, Placebo)

      Completed
      • Coronavirus Infection
      • Diabetes Mellitus, Type 2
      • Aarau, Switzerland
      • +8 more
      Sep 7, 2021

      Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure, Systolic Trial in Milwaukee (Lactobacillus Plantarum

      Recruiting
      • Heart Failure
      • +2 more
      • Lactobacillus Plantarum 299v Freeze Dried Capsule
      • Freeze Dried Potato Starch Capsule
      • Milwaukee, Wisconsin
        Medical College of Wisconsin
      Feb 21, 2023

      Platelet Aggregation, Spontaneous, Coronary Artery Disease Trial in São Paulo (Colchicine 0.5 MG, Placebo)

      Recruiting
      • Platelet Aggregation, Spontaneous
      • Coronary Artery Disease
      • Colchicine 0.5 MG
      • Placebo
      • São Paulo, Sao Paulo, Brazil
        Heart Institute (InCor) / University of São Paulo
      Jul 18, 2023

      Autoinflammatory Diseases

      Recruiting
      • NOMID
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 14, 2023

        Behcet Syndrome Trial in Tabriz (Zinc gluconate, Placebo)

        Completed
        • Behcet Syndrome
        • Zinc gluconate
        • Placebo
        • Tabriz, East Azerbaijan, Iran, Islamic Republic of
          Tabriz University of Medical Sciences
        Oct 27, 2021